Sleeping Aids Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2019 – 2030

The Global Sleeping Aids Market size is projected to surpass $138 Billion by 2030; with a CAGR of 6.7% from 2021 to 2030.

Sleeping Aids Market

Sleeping aids are a medical specialty or subspecialty devoted to the diagnosis and therapy of sleep disturbances and disorders which are caused due to factors such as psychiatric disorders (Depression, insomnia, and anxiety), medical issues (asthma), environmental problems (light, noise, temperature, etc.) and others. These sleep disorders lead to a number of chronic diseases, such as high diabetes, arthritis, blood pressure, and stroke. So, people are now aware of these disorders and trying to treat and diagnose these disorders at an early stage as soon as possible.

The rise in demand for sleeping pills, changing consumer lifestyle, increase in geriatric and obese population, the impact of pandemics such as COVID 19 and increasing disposable income are the factors propelling the growth of the global sleeping aids market. Rising awareness about sleep disorders and advanced technologies might provide several growth opportunities in the forecasted year. However, various side effects of sleep aids medication and patent expiration may hinder the growth of the market.

The global sleeping aids market is segmented on basis of product and sleep disorder. The sleeping aids market is segmented by products such as mattresses and pillows, sleep laboratories, medication (prescription based drugs, herbal drugs, OTC drugs), sleep apnea devices, and others. Further, the market is segmented by sleep disorders as insomnia, sleep apnea, restless legs syndrome, narcolepsy, sleep walking, and other sleep disorders.

Based on geography, the global sleeping aids market is segmented into North America, Europe, Asia Pacific, Rest of the World (RoW) North America is further bifurcated in U.S., Canada, and Mexico whereas Europe segment consist of UK, Germany, France, Italy, and others. Asia-Pacific is segmented into India, China, Japan, South Korea, and others while RoW is bifurcated into South America, the Middle East, and Africa.

Major companies operating in the global Sleeping Aids market are Natus Medical Incorporated, Teva Pharmaceutical Industries Limited, Takeda Pharmaceutical Company Limited, Merck And Co., Sanofi, GlaxoSmithKline Plc., Serta International, CareFusion Corporation, Pfizer, and Compumedics Limited, among others.

The key takeaways from the report

  • The detailed analysis of the Global Sleeping Aids Market with respect to key segments such as product, sleep disorder, and geography has been included in the report
  • The report comprises the qualitative and quantitative analysis of the market with market estimation over 2019 – 2030 and CAGR between 2021 and 2030
  • Comprehensive analysis of market dynamics including Growth factors, restraining factors, and opportunities will be provided in the report
  • An exhaustive regional and country-wise analysis of the Global Sleeping Aids Market has been covered in the report
  • Profile of the major key players operating in the Global Sleeping Aids Market will be provided, with a detailed study on their key financials, product & services, new developments, and business strategies.

Sleeping Aids Market

Scope of Global Sleeping Aids Market                                                                                   

Product Segments

  • Mattresses and Pillows
  • Sleep Laboratories
  • Medication
    • Prescription Based Drugs
    • Herbal Drugs
    • OTC drugs
  • Sleep Apnea Devices
  • Other Products

Sleep disorder Segments

  • Insomnia
  • Sleep Apnea
  • Restless Legs Syndrome
  • Narcolepsy
  • Sleep Walking
  • Other Sleep Disorders

Geographical Segments

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Others
  • Asia-Pacific
    • India
    • China
    • Japan
    • South Korea
    • Others
  • RoW
    • South America
    • Middle East
    • Africa

Back to top

Payment Options

Single User $2585.25
$3447
Five User $3881.25
$5175
Enterprise $6851.25
$9135
Datapack $974.25
$1299
Short Report: $1349.25
$1799